0
Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

³»°ú ÁßȯÀÚ½Ç È¯ÀÚÀÇ Ç÷´çÁ¶Àý ÇÁ·ÎÅäÄÝ Àû¿ë ¹× È¿°ú

Application and Effects of a Blood Glucose Control Protocol for Medical Intensive Care Unit Patients

ÁßȯÀÚ°£È£ÇÐȸÁö 2014³â 7±Ç 2È£ p.45 ~ 57
KMID : 1221920140070020045
±èÀº¼º ( Kim Eun-Sung ) - ¼¼ºê¶õ½ºº´¿ø °£È£ºÎ

ÃÖ½º¹Ì ( Choi-Kwon Smi ) - ¼­¿ï´ëÇб³ °£È£´ëÇÐ
±è¿µ»ï ( Kim Young-Sam ) - ¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇРȣÈí±â³»°ú

Abstract

Purpose: The purpose of this study was to examine the effect of a blood glucose control protocol for medical intensive care unit (ICU) patients.

Methods: The subjects were recruited from medical ICU adult patients whose blood glucose levels exceeded 200 mg/dL in two consecutive tests. The experimental group (n=62) received the modified Yale (MY) insulin protocol, whereas the control group (n=64) was treated with the conventional insulin therapy methods.

Results: In the experimental group, the mean blood glucose levels (p<.001) and the time to reach the target range of glucose (p<.001) decreased significantly while the incidence rates of a target range of glucose of 100-140 mg/dL (p<.001) increased significantly as compared to the control group. However, no statistically significant differences were found in the incidence of hypoglycemia(p=.644), or the number of glucose tests (p=.236) between the groups. The length of stays in the ICU (p=.001), ventilator care days (p=.038), and the Sequential Organ Failure Assessment (SOFA) score (p=.029) in the experimental group were significantly lower than those of the control group.

Conclusion: Application of the protocol was effective in improving the state of blood glucose control in medical ICU patients. Therefore, this protocol is expected to be used as a part of nursing intervention in critical care nursing.
KeyWords
ÁßȯÀÚ °£È£, ÀÓ»ó ÇÁ·ÎÅäÄÝ, °íÇ÷´çÁõ, Àν¶¸°, ÀÓ»óÁöÇ¥
Critical care, Clinical protocol, Hyperglycemia, Insulin, Clinical markers
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
ÇмúÁøÈïÀç´Ü(KCI)